Description

GLP-2 TZ

Dual Incretin Agonist (GLP-1 / GIP) / Advanced Metabolic Modulator

GLP-2 TZ is a dual incretin receptor agonist, combining the effects of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).

This dual mechanism is studied regarding impacts on weight loss, improved glucose metabolism, and superior energy utilization compared to GLP-1 analogues alone. It is researched for comprehensive metabolic optimization, influencing appetite control, insulin sensitivity, lipid metabolism, and mitochondrial efficiency.

RESEARCH

GLP-2 TZ is a synthetic peptide analog formulated exclusively for in vitro research involving analog stability and structural modeling. It is intended solely for laboratory studies focused on analog stability and structural modeling. It has been studied in non-clinical environments for its potential for resisting enzymatic breakdown and enhancing receptor interaction modeling in controlled research setting.

Chemical Information:

• Molecular Formula: C225 H348 N48 O68
• Molecular Weight: 4813.45 Da
• CAS Number: 2931515-08-9

Research Applications:

• Structural investigation of peptide analog stability
• Modeling of receptor-ligand binding interactions in assay conditions
• Conjugation strategy comparisons in synthetic research
• Environmental degradation and preservation analysis under lab simulation

Storage and Handling:

• Store lyophilized powder at -20°C
• Once reconstituted, store at 2–8°C and use promptly
• Use aseptic handling protocols to preserve sterility

Product Specifications:

• Purity: ≥99% (HPLC Verified)
• Appearance: Lyophilized white powder
• Solubility: Soluble in bacteriostatic water

Compliance Notice:

GLP-2 TZ is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA and is not to be used for therapeutic, diagnostic, or clinical purposes. Any misuse of this product may violate applicable laws and regulations. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.

Benefits being Researched:

• Weight loss by combining GLP-1 and GIP receptor activation
• Glucose regulation and insulin responsiveness
• Visceral and total body fat while preserving lean muscle
• Lowers triglycerides and cholesterol, supporting cardiovascular health
• Satiety and appetite regulation through dual hypothalamic pathways
• Energy expenditure and metabolic rate

Mechanism of Action (Simplified):

• GLP-1 receptor activation:
  • Increases insulin secretion in a glucose-dependent manner
  • Slows gastric emptying and suppresses appetite
• GIP receptor activation:
  • Improves insulin sensitivity in adipose and muscle tissue
  • Enhances glucose uptake and energy efficiency
• Dual synergy: results in superior fat oxidation, appetite suppression, and glycemic balance compared to single-pathway incretins

Form / Notes:

• Lyophilized vials for reconstitution
• Standard dual incretin dosing for research use

LEGAL DISCLAIMER

This product is sold strictly for laboratory research use only.

By purchasing this product, the buyer represents and warrants that:

• The material will be used solely for in-vitro research purposes
• The buyer is qualified to handle laboratory reagents
• The product will not be used for human or animal consumption, injection, or application

Revyon Technologies assumes no liability for misuse or improper handling.

IMPORTANT NOTICE

Any use outside of stated research purposes is strictly prohibited.